Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-14 4:30 pm Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Panacea Venture Healthcare Fund II, L.P. | 0 0.000% | -5,500,000![]() (Position Closed) | Filing History |
2025-02-14 4:00 pm Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | TANG CAPITAL PARTNERS LP | 1,641,945 3.000% | -2,860,912![]() (-63.54%) | Filing History |
2025-02-12 6:40 pm Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Sofinnova Investments Inc. | 0 0.000% | -4,386,177![]() (Position Closed) | Filing History |
2025-02-11 8:45 pm Purchase | 2025-02-07 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 3,022,612 5.500% | 917,348![]() (+43.57%) | Filing History |
2025-02-11 8:20 pm Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,105,264 3.800% | -3,358,377![]() (-61.47%) | Filing History |
2025-02-11 11:08 am Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | FRANKLIN RESOURCES INC BEN | 0 0.000% | -4,713,014![]() (Position Closed) | Filing History |
2025-02-04 2:13 pm Purchase | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | MORGAN STANLEY MS | 3,298,215 6.000% | 3,298,215![]() (New Position) | Filing History |
2025-01-31 12:14 pm Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | VANGUARD GROUP INC | 2,596,768 4.700% | -206,197![]() (-7.36%) | Filing History |
2025-01-07 7:15 pm Purchase | 2024-12-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Beryl Capital Management LLC | 5,462,942 9.900% | 5,462,942![]() (New Position) | Filing History |
2024-11-15 10:35 am Sale | 2024-11-14 | 13G | Marinus Pharmaceuticals, Inc. MRNS | PRUDENTIAL FINANCIAL INC PRU | 385,250 0.700% | -2,924,741![]() (-88.36%) | Filing History |
2024-11-14 6:39 pm Purchase | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Sofinnova Investments Inc. | 4,386,177 8.000% | 4,386,177![]() (New Position) | Filing History |
2024-11-14 3:04 pm Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Cormorant Asset Management LP | 0 0.000% | -3,250,000![]() (Position Closed) | Filing History |
2024-11-14 12:24 pm Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -4,529,997![]() (Position Closed) | Filing History |
2024-11-14 09:34 am Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Avoro Capital Advisors LLC | 0 0.000% | -3,150,000![]() (Position Closed) | Filing History |
2024-11-12 4:01 pm Unchanged | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | VANGUARD GROUP INC | 2,802,965 5.080% | 0 (Unchanged) | Filing History |
2024-11-12 09:55 am Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | JENNISON ASSOCIATES LLC | 0 0.000% | -2,959,161![]() (Position Closed) | Filing History |
2024-11-04 1:43 pm Purchase | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | VANGUARD GROUP INC | 2,802,965 5.080% | 2,802,965![]() (New Position) | Filing History |
2024-11-01 8:30 pm Purchase | 2024-10-25 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Panacea Venture Healthcare Fund II, L.P. | 5,500,000 9.980% | 5,500,000![]() (New Position) | Filing History |
2024-10-31 1:05 pm Purchase | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | FRANKLIN RESOURCES INC BEN | 4,713,014 8.600% | 879,059![]() (+22.93%) | Filing History |
2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | BlackRock Inc. BLK | 1,869,949 3.400% | -2,729,329![]() (-59.34%) | Filing History |